<?xml version="1.0" encoding="UTF-8"?>
<crossref_result xmlns="http://www.crossref.org/qrschema/3.0" version="3.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/qrschema/3.0 http://www.crossref.org/schemas/crossref_query_output3.0.xsd">
  <query_result>
    <head>
      <doi_batch_id>none</doi_batch_id>
    </head>
    <body>
      <query status="resolved">
        <doi type="journal_article">10.31254/phyto.2024.13209</doi>
        <crm-item name="publisher-name" type="string">BioMed Research Publishers</crm-item>
        <crm-item name="prefix-name" type="string">BioMed Research Publishers</crm-item>
        <crm-item name="member-id" type="number">16195</crm-item>
        <crm-item name="citation-id" type="number">160629331</crm-item>
        <crm-item name="journal-id" type="number">316921</crm-item>
        <crm-item name="deposit-timestamp" type="number">20240512122131292</crm-item>
        <crm-item name="owner-prefix" type="string">10.31254</crm-item>
        <crm-item name="last-update" type="date">2024-05-12T16:21:40Z</crm-item>
        <crm-item name="created" type="date">2024-05-12T16:21:38Z</crm-item>
        <crm-item name="citedby-count" type="number">1</crm-item>
        <doi_record>
          <crossref xmlns="http://www.crossref.org/xschema/1.1" xsi:schemaLocation="http://www.crossref.org/xschema/1.1 http://doi.crossref.org/schemas/unixref1.1.xsd">
            <journal>
              <journal_metadata>
                <full_title>The Journal of Phytopharmacology</full_title>
                <abbrev_title>J Phytopharmacol</abbrev_title>
                <issn media_type="electronic">2320480X</issn>
                <doi_data>
                  <doi>10.31254/phyto</doi>
                  <resource>https://www.phytopharmajournal.com/</resource>
                </doi_data>
              </journal_metadata>
              <journal_issue>
                <publication_date media_type="online">
                  <month>4</month>
                  <day>30</day>
                  <year>2024</year>
                </publication_date>
                <journal_volume>
                  <volume>13</volume>
                </journal_volume>
                <issue>2</issue>
              </journal_issue>
              <journal_article publication_type="full_text">
                <titles>
                  <title>Thermoxidized palm oil diet (TPO) induced protein derangements in rats is ameliorated by fresh palm oil (FPO) and Vitamin E</title>
                </titles>
                <contributors>
                  <person_name sequence="first" contributor_role="author">
                    <given_name>Imoh Emmanuel</given_name>
                    <surname>Ukoh</surname>
                    <ORCID>https://orcid.org/0000-0002-5195-5873</ORCID>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Idongesit Bassey</given_name>
                    <surname>Umoh</surname>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Enene Esu</given_name>
                    <surname>Ukpai</surname>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Samuel Kelechi</given_name>
                    <surname>Mobisson</surname>
                    <ORCID>https://orcid.org/0000-0002-7392-2976</ORCID>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Ikete Precious</given_name>
                    <surname>Whiskey</surname>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Perowei</given_name>
                    <surname>Azosibe</surname>
                    <ORCID>https://orcid.org/0009-0006-1228-5850</ORCID>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Azibaobom</given_name>
                    <surname>Karibi</surname>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Ukrakpo Oghenemega</given_name>
                    <surname>Sophia</surname>
                    <ORCID>https://orcid.org/0009-0008-0606-3084</ORCID>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Adienbo Emmemodi</given_name>
                    <surname>Nwadighi</surname>
                  </person_name>
                </contributors>
                <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xml:lang="en">
                  <jats:p>Objective(s): The therapeutic efficacy of FPO and vitamin E were studied against TPO induced derangements in some proteins in rats. Materials and Methods: 60 male albino rats (140-160g) weight range, grouped (n=10) as: Control, TPO, FPO, Vitamin E, TPO treated with FPO (TPO+FPO) and Vitamin E (TPO+ Vitamin E). TPO and FPO (15g each) mixed with 85g rat feed was used to prepare FPO and TPO diet. Vitamin E was administered 200mg/kg daily by oral gavage. Animals were fed for 4 weeks, while group 5 and 6 were further treated with FPO and Vitamin E for another 4 weeks. At the end of the experiment blood were collected from sacrificed rats via cardiac puncture and protein indices were analyzed using serum. Results: Sero-protein analysis revealed a significant reduction in total protein, albumin, globulin and albumin-globulin ratio in TPO compared to control, FPO and Vitamin E, but was significantly increased in TPO+FPO and TPO+ Vitamin E compared to TPO. Total protein was significantly increased in TPO+FPO compared to TPO+ Vitamin E, while globulin was significantly increased in TPO+ Vitamin E compared to TPO+FPO. Total bilirubin and unconjugated bilirubin were significantly increased in TPO compared to control, FPO and Vitamin E, but was significantly reduced in TPO+FPO and TPO+ Vitamin E compared to TPO. Total bilirubin was significantly reduced in TPO+FPO compared to TPO+ Vitamin E. Conjugated bilirubin was significantly reduced in TPO compared to control, FPO and Vitamin E, but was significantly increased in TPO groups treated with FPO and Vitamin E in relation to TPO. Conclusion: FPO and vitamin E displayed therapeutic efficacy in ameliorating protein derangements instigated by TPO consumption.</jats:p>
                </jats:abstract>
                <publication_date media_type="online">
                  <month>4</month>
                  <day>30</day>
                  <year>2024</year>
                </publication_date>
                <pages>
                  <first_page>154</first_page>
                  <last_page>159</last_page>
                </pages>
                <crossmark>
                  <crossmark_version>1</crossmark_version>
                  <crossmark_policy>10.31254/biomed-crossmark-policy</crossmark_policy>
                  <crossmark_domains>
                    <crossmark_domain>
                      <domain>www.biomedresearch.org</domain>
                    </crossmark_domain>
                  </crossmark_domains>
                  <crossmark_domain_exclusive>false</crossmark_domain_exclusive>
                </crossmark>
                <doi_data>
                  <doi>10.31254/phyto.2024.13209</doi>
                  <resource>https://www.phytopharmajournal.com/assets/pdf_files/Vol13_Issue2_09.pdf</resource>
                </doi_data>
              </journal_article>
            </journal>
          </crossref>
        </doi_record>
      </query>
    </body>
  </query_result>
</crossref_result>